Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pancreatic Neoplasms × infigratinib × Clear all

Sponsor

Conditions

Glioblastoma 2 Cholangiocarcinoma 2 Upper Tract Urothelial Carcinomas 1 Squamous Cell Carcinoma of Head and Neck 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Hematologic Neoplasms 1 Glioma 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1

Interventions

Gemcitabine 141 Fluorouracil 41 Capecitabine 39 130-nm albumin-bound paclitaxel 39 Oxaliplatin 37 Albumin-Bound Paclitaxel 35 Leucovorin 31 Erlotinib Hydrochloride 29 Radiotherapy 20 Irinotecan 20 Bevacizumab 19 pembrolizumab 18 Radiosurgery 16 Docetaxel 16 Cyclophosphamide 15 Taxes 11 Cisplatin 11 Cetuximab 11 folfirinox 9 Nivolumab 9 Ipilimumab 7 Standard of Care 6 Radiation 6 spartalizumab 5 durvalumab 5 dehydroftorafur 5 Surgical Procedures, Operative 5 Paclitaxel 5 Hydroxychloroquine 5 Ascorbic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡